Oncogenic virus in oral squamous cell carcinoma and the role of oncolytic HSV-1 viro-immunotherapy as an emerging treatment

被引：3
|
作者：
Saravanan, Muthupandian [1 ]
Omole, Richard Kolade [1 ,2 ]
Torimiro, Nkem [2 ]
机构：
[1] Saveetha Inst Med & Tech Sci SIMATS, Saveetha Dent Coll & Hosp, Dept Pharmacol, AMR & Nanotherapeut Lab, Chennai 600077, Tamil Nadu, India
[2] Obafemi Awolowo Univ, Dept Microbiol, Ife 220005, Nigeria
来源：
ORAL ONCOLOGY | 2022年 / 133卷
关键词：
D O I：
10.1016/j.oraloncology.2022.106021
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] ONCOLYTIC HERPES SIMPLEX VIRUS 1 (HSV-1) VECTORS: INCREASING TREATMENT EFFICACY AND RANGE THROUGH STRATEGIC VIRUS DESIGN
    Carson, J.
    Haddad, D.
    Bressman, M.
    Fong, Y.
    DRUGS OF THE FUTURE, 2010, 35 (03) : 183 - 195
  • [22] Novel Oncolytic HSV-1 for the Treatment of Prostate Carcinoma with Improved Efficacy Independent of Tumor Growth Rate
    Takeshima, Yuta
    Fukuhara, Hiroshi
    Hou, Jiangang
    Homma, Yukio
    Ino, Yasushi
    Todo, Tomoki
    MOLECULAR THERAPY, 2012, 20 : S79 - S80
  • [23] Role of Immunotherapy in the Treatment of Squamous Cell Carcinoma of the Anal Canal
    Morris, Van K.
    Eng, Cathy
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (07): : 903 - 908
  • [24] Morphine treatment restricts response to immunotherapy in oral squamous cell carcinoma
    Mcilvried, Lisa A.
    Martel Matos, Andre A.
    Yuan, Mona M.
    Atherton, Megan A.
    Obuekwe, Fendi
    Nilsen, Marci L.
    Nikpoor, Amin Reza
    Talbot, Sebastien
    Bruno, Tullia C.
    Taggart, David N.
    Johnson, Lorin K.
    Ferris, Robert L.
    Zandberg, Dan P.
    Scheff, Nicole N.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (11)
  • [25] Emerging Role of Autophagy in the Development and Progression of Oral Squamous Cell Carcinoma
    Abd El-Aziz, Yomna S.
    Leck, Lionel Y. W.
    Jansson, Patric J.
    Sahni, Sumit
    CANCERS, 2021, 13 (24)
  • [26] Bortezomib Treatment Sensitizes Oncolytic HSV-1-Treated Tumors to NK Cell Immunotherapy
    Yoo, Ji Young
    Jaime-Ramirez, Alena Cristina
    Bolyard, Chelsea
    Dai, Hongsheng
    Nallanagulagari, Tejaswini
    Wojton, Jeffrey
    Hurwitz, Brian S.
    Relation, Theresa
    Lee, Tae Jin
    Lotze, Michael T.
    Yu, Jun-Ge
    Zhang, Jianying
    Croce, Carlo M.
    Yu, Jianhua
    Caligiuri, Michael A.
    Old, Matthew
    Kaur, Balveen
    CLINICAL CANCER RESEARCH, 2016, 22 (21) : 5265 - 5276
  • [27] Potential for efficacy of the oncolytic herpes simplex virus 1716 in patients with oral squamous cell carcinoma
    Mace, Alastair T. M.
    Ganly, Ian
    Soutar, David S.
    Brown, S. Moira
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2008, 30 (08): : 1045 - 1051
  • [28] The effects of trichostatin A on the oncolytic ability of herpes simplex virus for oral squamous cell carcinoma cells
    T Katsura
    S Iwai
    Y Ota
    H Shimizu
    K Ikuta
    Y Yura
    Cancer Gene Therapy, 2009, 16 : 237 - 245
  • [29] The effects of trichostatin A on the oncolytic ability of herpes simplex virus for oral squamous cell carcinoma cells
    Katsura, T.
    Iwai, S.
    Ota, Y.
    Shimizu, H.
    Ikuta, K.
    Yura, Y.
    CANCER GENE THERAPY, 2009, 16 (03) : 237 - 245
  • [30] A novel fusogenic herpes simplex virus mutant for oncolytic virotherapy of oral squamous cell carcinoma
    Yura, Y.
    Takaoka, H.
    Ogawa, F.
    Shintani, M.
    Iwai, S.
    ORAL ONCOLOGY, 2009, : 93 - 94
12345